No Result

View All Result

No products in the cart.

Home Tag stem cell transplant

Tag: stem cell transplant

No clinical benefit of specific immunotherapy seen in lymphoma

Allogeneic stem cell transplantation improves progression-free survival in advanced cutaneous T-cell lymphomas

byNeel Mistryand1 others

June 27, 2023

1. Median progression-free survival in the HSCT group was significantly longer than in the non-HSCT group. 2. HSCT was associated ...

#VisualAbstract Ponatinib with FLAG-IDA is a feasible and active treatment strategy in patients with blast-phase chronic myeloid leukaemia

byKathleen Lau

June 12, 2022

#VisualAbstract Underlying multiple myeloma remains the primary cause of death across all age groups of patients and across all lines of therapy

byKathleen Lau

August 6, 2021

#VisualAbstract Post-transplant cyclophosphamide is associated with increased incidence of cytomegalovirus infection in hematopoietic cell transplant recipients

byKathleen Lau

June 25, 2021

#VisualAbstract Lenalidomide shows improvement in progression-free survival over bortezomib maintenance following autologous stem cell transplantation for multiple myeloma

byKathleen Lau

January 28, 2021

#VisualAbstract Higher rate of hematologic second primary malignancies developed in multiple myeloma patients who received autologous hematopoietic stem cell transplants

byKathleen Lau

January 21, 2021

#VisualAbstract Fondazione Italiana Linfomi (FIL) Phase 3 trial: Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation (HSCT) in mantle cell lymphoma improves progression-free survival (PFS)

byKathleen Lau

January 8, 2021

#VisualAbstract GIMEMMA-MMY-3006: Bortezomib, Thalidomide, and Dexamethasone (VTD) Followed By Stem-Cell Transplantation Improves Long-Term Survival Outcomes in Newly Diagnosed Multiple Myeloma (MM)

byKathleen Lau

December 25, 2020

Check out the original article from the Lancet Haematology here.

#VisualAbstract CASSIOPEIA Part 1: Bortezomib, Thalidomide, and Dexamethasone with Daratumumab (D-VTd) May Improve Quality of Life Post-Consolidation in Newly Diagnosed, Transplantation-Eligible Multiple Myeloma (MM) Patients

byKathleen Lau

December 24, 2020

Check out the original article from the Lancet Haematology here.

#VisualAbstract Melphalan 200mg/m2 Versus Reduced Doses of Melphalan in Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation

byKathleen Lau

December 18, 2020

Page 1 of 2 1 2 Next

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result